Cargando…

Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study

BACKGROUND: A recent study shows that dual antiplatelet therapy with clopidogrel plus aspirin is superior to aspirin monotherapy for minor stroke, which is defined as a National Institutes of Health Stroke Scale (NIHSS)score of ≤3. However, acute mild-moderate ischaemic stroke (4≤NIHSS≤10) still nee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Xiaowen, Li, Xiaoqiu, Wang, Xinhong, Chen, Huisheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312068/ https://www.ncbi.nlm.nih.gov/pubmed/30637134 http://dx.doi.org/10.1136/svn-2018-000148

Ejemplares similares

Genome sequencing and analysis of two early-flowering cherry (Cerasus × kanzakura) varieties, ‘Kawazu-zakura’ and ‘Atami-zakura’
por: Shirasawa, Kenta, et al.
Publicado: (2021)

Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis
por: Li, Xiao‐Qiu, et al.
Publicado: (2022)

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
por: Tang, Wei, et al.
Publicado: (2020)

A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer
por: Kim, Hee Seung, et al.
Publicado: (2020)

Questions Regarding the Initial Request for the Dispatch of Disaster Medical Assistance Teams for a Landslide after Torrential Rain at Izuyama in Atami, Japan
por: Yanagawa, Youichi, et al.
Publicado: (2022)

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
por: Hinks, Timothy S C, et al.
Publicado: (2021)

Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trial
por: Hu, Xiangming, et al.
Publicado: (2023)

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial
por: Barco, Stefano, et al.
Publicado: (2022)

Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial
por: Toyoda, Kazunori, et al.
Publicado: (2015)

Dual versus mono antiplatelet therapy in mild‐to‐moderate stroke during hospitalization
por: Fan, Haimei, et al.
Publicado: (2022)

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
Publicado: (2019)

Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)
por: Brennan, Paul Noel, et al.
Publicado: (2021)

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Publicado: (2020)

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
por: Agarwal, Anup, et al.
Publicado: (2020)

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study
por: Beigel, John H, et al.
Publicado: (2017)

Inased (inhaled sedation in ICU) trial protocol: a multicentre randomised open-label trial
por: Bailly, Pierre, et al.
Publicado: (2021)

Shunting outcomes in communicating hydrocephalus: protocol for a multicentre, open-label, randomised controlled trial
por: Sun, Tong, et al.
Publicado: (2021)

Comparison of a preventive or curative strategy of fluid removal on the weaning of mechanical ventilation: a study protocol for a multicentre randomised open-label parallel-group trial
por: Dres, Martin, et al.
Publicado: (2021)

Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial
por: Mwangi, Martin N, et al.
Publicado: (2021)

Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial
por: Labbe, Vincent, et al.
Publicado: (2022)

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
por: Li, Shuya, et al.
Publicado: (2021)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
por: Ravichandran, Rajan, et al.
Publicado: (2022)

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial
por: Jongsma, Maria M E, et al.
Publicado: (2022)

A randomised, open‐label, parallel‐group, multicentre, comparative study to compare the efficacy and safety of Exufiber® with Aquacel® Extra™ dressings in exuding venous and mixed aetiology leg ulcers
por: Joergensen, Bo, et al.
Publicado: (2022)

Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial
por: Armitage, Kelsey Fiona, et al.
Publicado: (2023)

Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer’s dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial
por: Park, Kyung Won, et al.
Publicado: (2017)

A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly
por: Trainer, Peter J, et al.
Publicado: (2018)

Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study
por: Ayashi, Saleh, et al.
Publicado: (2016)

A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
por: Fowotade, Adeola, et al.
Publicado: (2022)

Multicentre, open-label, randomised controlled clinical trial to assess the efficacy and safety of appropriate target values for lipid management in patients who have mild-to-moderate stenotic lesions with high-risk plaques in coronary arteries: study protocol
por: Matsuda, Morihiro, et al.
Publicado: (2019)

Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study
por: Wu, Zexuan, et al.
Publicado: (2020)

Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial
por: Gnessi, Lucio, et al.
Publicado: (2015)

The Use of Alfa-Lipoic Acid-R (ALA-R) in Patients with Mild-Moderate Carpal Tunnel Syndrome: A Randomised Controlled Open Label Prospective Study
por: Passiatore, M, et al.
Publicado: (2020)

Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial
por: Schmidt, Katharina, et al.
Publicado: (2021)

Remotely delivered cognitive behavioural and personalised exercise interventions for fatigue severity and impact in inflammatory rheumatic diseases (LIFT): a multicentre, randomised, controlled, open-label, parallel-group trial
por: Bachmair, Eva-Maria, et al.
Publicado: (2022)

Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux Disease
por: Marakhouski, KY, et al.
Publicado: (2017)

Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
por: Yamamoto, Kazuko, et al.
Publicado: (2021)

Moderate-to-vigorous group aerobic exercise versus group leisure activities for mild-to-moderate depression in adolescents: study protocol for a multicentre randomised controlled trial
por: Mortazavi, Rebecca, et al.
Publicado: (2022)

A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
por: Matsuda, M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7tee66l3ud6m33dqd1oepofuih